Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

On-pump, off-pump CABG have similar long-term outcomes

After five years of follow-up, patients with coronary artery disease had similar rates of the composite outcome of death, stroke, MI, renal failure or repeat revascularization whether they underwent off-pump or on-pump CABG, according to a randomized trial.

Public health experts offer advice about heart surgery infections

According to the Centers for Disease Control and Prevention (CDC), more than half a million patients who underwent open-heart surgery since 2012 could have been exposed to a type of nontuberculosis mycobacteria (NTM).

Prosthetic heart valve market anticipates continued steady growth

The U.S. prosthetic heart valve market is expected to reach $6.3 billion by the end of 2016, according to a new report from Future Market insights, a New York-based market intelligence and consulting firm.

Study highlights need for new options within heart failure treatment paradigm

Stealth BioTherapeutics' phase 2 study examines whether treatment for myocardial dysfunction will relieve congestive heart failure.  

Adherence to medications may improve long-term outcomes following CABG, PCI

Patients who adhered to their medical therapy for up to eight years after undergoing CABG or PCI had significantly fewer major adverse cardiac events compared with those who did not adhere to their treatment, according to a retrospective, observational study.

Hospitals print 3D models of patients’ hearts before surgery

A few doctors and hospitals print 3D models of patients’ hearts to help prepare them for surgeries, the Chicago Tribune reports.

Timely corticosteroid treatment benefits those with Kawasaki disease

Patients with Kawasaki disease who received corticosteroids plus intravenous immunoglobulin (IVIG) therapy had a reduced risk of coronary artery complications compared with IVIG therapy alone, according to a systematic review and meta-analysis.

15 takeaways from the AHA statement on drug interactions with statins

The American Heart Association (AHA) recently published a set of recommendations for drug on drug interactions with the use of statins in patients with cardiovascular disease.

Displaying 1265 - 1272 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.